Insights

Insight
May 2020

The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?

Insight
May 2020

In Memoriam Adam Wagstaff 1959-2020

Insight
April 2020

The Digitalisation of Health Care During COVID-19: Consideration of the Long-Term Consequences

Insight
February 2020

Do child QALYs = adult QALYs? Five reasons why they might not

Insight
December 2019

25 Years of the Cost Effectiveness Acceptability Curve

Insight
October 2019

NICE and EuroQol Research Foundation to Support New EQ-5D-5L Valuation Study

Insight
September 2019

A Market-based International Reference Price Index: Solution or Contradiction?

Insight
May 2019

We Asked, You Answered: Reflections on the First Round of MVAC Feedback

Insight
March 2019

HTA in Japan: Failing to Meet International Good Practice?

Insight
September 2018

As UN General Assembly Highlights Tuberculosis Fight, Will BRICS Lead on the R&D Agenda?

Insight
September 2018

MoCA Initiative and its Value Framework: An Opportunity to Improve Decision Making for Orphan Drugs in Europe?

Insight
August 2018

NICE Recommendation Highlights Role of Social Value Judgements

Newsroom

The latest news and comment from OHE experts

Read Now

Subscribe To Our Newsletter

Our monthly Bulletin highlights our work alongside the latest from across health economics and health care.

News and Insights

Latest Research & Publications

A Bargaining Approach: A Theory on ICER Pricing and Optimal Level of Cost-Effectiveness Threshold

NICE ‘Optimised’ Decisions: What is the Recommended Level of Patient Access?

Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies

International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making

Personalised Medicine: is it an Oil-Rush or Oil-Spill?

Indication-Based Pricing (IBP) Consultation Report

Closing the ‘Know-Do’ Gap for Health Systems Reform at the Policy Level

The Evolution of US Policy Responses to the Opioid Epidemic

All Publications

Filter results by

Around the World in HTAs: Canada – Autonomous yet Collaborative

Driving Green Change: Lessons from the 2024 Innovation Policy Prize

Filter results by

The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?

In Memoriam Adam Wagstaff 1959-2020

The Digitalisation of Health Care During COVID-19: Consideration of the Long-Term Consequences

Do child QALYs = adult QALYs? Five reasons why they might not

25 Years of the Cost Effectiveness Acceptability Curve

NICE and EuroQol Research Foundation to Support New EQ-5D-5L Valuation Study

A Market-based International Reference Price Index: Solution or Contradiction?

We Asked, You Answered: Reflections on the First Round of MVAC Feedback

HTA in Japan: Failing to Meet International Good Practice?

As UN General Assembly Highlights Tuberculosis Fight, Will BRICS Lead on the R&D Agenda?

MoCA Initiative and its Value Framework: An Opportunity to Improve Decision Making for Orphan Drugs in Europe?

NICE Recommendation Highlights Role of Social Value Judgements

Newsroom

Subscribe To Our Newsletter

Share on Mastodon